Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × Bevacizumab × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Ovarian Neoplasms 17 Carcinoma, Hepatocellular 13 Fallopian Tube Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Neoplasms 9 Colonic Neoplasms 8 Rectal Neoplasms 6 Brain Neoplasms 6 Lung Neoplasms 5 Liver Neoplasms 5 Endometrial Neoplasms 5 Uterine Cervical Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Glioblastoma 3 Carcinoma, Renal Cell 3 Carcinoma, Pancreatic Ductal 3 Carcinoma, Ovarian Epithelial 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Lymphoid Interstitial Pneumonia 2 Gastrointestinal Neoplasms 2 Colorectal Adenocarcinoma 2 Carcinoma, Merkel Cell 2

Interventions

ibrutinib 4 Rituximab 4 zanubrutinib 3 venetoclax 2 ixazomib 2 Prednisone 2 Cyclophosphamide 2 CT-P10 2 talquetamab 1 pirtobrutinib 1 fludarabine 1 brexucabtagene autoleucel 1 Vincristine 1 Valacyclovir 1 Specimen Handling 1 Sirolimus 1 Pharmacogenomic Variants 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Everolimus 1 Etoposide 1 Doxorubicin 1 Bortezomib 1 Biopsy 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡